MedTrace Logo

European Study of Cardiovascular Risk

NCT00882336 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7200

Last updated 2009-10-29

No results posted yet for this study

Summary

The main objective of this study is to describe the management of patients with cardiovascular risk factors in primary prevention among different European countries.

The patient's participation consists of a single study visit during a routine visit of the patient to the clinic/office.

Study variables will be measured:

* By an interview between physician and patient during the visit and/or available medical records' information: social and demographic patient characteristics, relevant family medical history, current medication.
* By questions asked to the physician: physician perception of patients' CV risk factor, guidelines adherence and cost-containment.
* By measurement performed to the patient during the visit: weight, height, BMI, waist and hip circumference will be measured.
* CV risk factors (blood parameters) will be measured by collecting available data documented within the last year in the medical records and by the collection and analyses of a blood sample during the visit.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Elvira Massó · AstraZeneca Spain

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Completion
2009-10-31

Countries

  • Austria
  • Belgium
  • France
  • Germany
  • Greece
  • Norway
  • Russia
  • Spain
  • Sweden
  • Switzerland
  • Turkey (Türkiye)
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00882336 on ClinicalTrials.gov